Browse studies

Find your next paid study

1 recruiting study matching your filters

Renal Retention in High Grade Upper Tract Urothelial Cancer: A Phase II Trial of Enfortumab Vedotin and Pembrolizumab in Patients With Upper Tract Urothelial Cancer (UTUC) Who Are Not Candidates for, or Refuse, Nephroureterectomy

This trial will evaluate the use of combination pembrolizumab and enfortumab vedotin for patients with high grade non-metastatic (cN0/NxMx, no measurable regio…

High Grade Urothelial CarcinomaBladder CancerUrothelial Carcinoma Bladder

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsNCT05656235